You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Incurable Platinum Refractory Germ Cell Tumors

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Cangzhou (oncolytic virus (OVV-01) injection)

Recruiting
  • Neoplasms
  • oncolytic virus (OVV-01) injection
  • Cangzhou, HE BEI, China
    North China Petroleum Bureau General Hospital
Jul 1, 2021

Microbiome Composition and Function Contributes to Cognitive

Recruiting
  • Parkinson Disease
    • San Bernardino, California
      California State University San Bernardino
    Jun 10, 2022

    Blasts Under 5 Percent of Peripheral Blood White Cells, Bone Marrow Blasts Decreased by 50 Percent or More Compared to

    Withdrawn
    • Blasts Under 5 Percent of Peripheral Blood White Cells
    • +4 more
    • Buffalo, New York
    • +1 more
    Mar 8, 2021

    Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

    Completed
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • HyperAcute®-Renal (HAR) Immunotherapy
    • Iowa City, Iowa
    • +2 more
    Apr 4, 2022

    Rheumatoid Arthritis Trial in Nanjing (Sacral nerve stimulation, Sham stimulation)

    Recruiting
    • Rheumatoid Arthritis
    • Sacral nerve stimulation
    • Sham stimulation
    • Nanjing, Jiangsu, China
      Dinglei Su
    Mar 3, 2022

    Cancer Trial in Hackensack (relatlimab, nivolumab, rHuPH20)

    Active, not recruiting
    • Cancer
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Sep 13, 2021

    Responsiveness in Oncology Patients Based on Host Response

    Recruiting
    • Non Small Cell Lung Cancer
    • Healthy
    • blood, stool and tissue samples collection
    • Dallas, Texas
      Baylor Scott and White Research Institute
    Feb 9, 2023

    NSCLC Trial in Worldwide (Amivantamab, Osimertinib, Lazertinib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Goodyear, Arizona
    • +266 more
    Aug 17, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

    Available
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +4 more
    • Stanford, California
    • +61 more
    Aug 17, 2022

    Non Clear Cell Renal Carcinoma Trial in Guangzhou (Anlotinib plus Sintilimab)

    Not yet recruiting
    • Non Clear Cell Renal Carcinoma
    • Anlotinib plus Sintilimab
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Feb 1, 2022

    Newly Diagnosed High-Grade Glioma Trial in Baltimore (Mebendazole)

    Completed
    • Newly Diagnosed High-Grade Glioma
    • Baltimore, Maryland
      The Johs Hopkins Hospital
    May 6, 2021

    Healthy Trial in United States (Filgrastim)

    Recruiting
    • Healthy
    • Duarte, California
    • +19 more
    Mar 7, 2022

    Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

    Recruiting
    • Non Small Cell Lung Cancer
    • Nashville, Tennessee
      Vanderbilt Ingram Cancer Center
    Jun 28, 2022

    Non-ischemic Dilated Cardiomyopathy Trial in United States (allogeneic human mesenchymal stem cells (hMSCs), Placebo)

    Recruiting
    • Non-ischemic Dilated Cardiomyopathy
    • allogeneic human mesenchymal stem cells (hMSCs)
    • Placebo
    • Stanford, California
    • +3 more
    Mar 23, 2022

    Coronary Arteriosclerosis Trial in Paris (injection of 68Ga-DOTATATE)

    Terminated
    • Coronary Arteriosclerosis
    • injection of 68Ga-DOTATATE
    • Paris, France
      service de médecine nucléaire-Hôpital Bichat
    Jun 29, 2022

    Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Abbotsford (Bevacizumab)

    Not yet recruiting
    • Ovarian Cancer
    • Platinum-resistant Ovarian Cancer
    • Abbotsford, British Columbia, Canada
      Abbotsford Centre, BC Cancer Agency
    Jul 19, 2021

    Adrenal and Other Endocrine Tumors in Patients With Sudden Death

    Recruiting
    • Primary Aldosteronism
    • +3 more
    • Adrenal aldosterone synthase (CYP11B2) staining
    • +2 more
    • Helsinki, Finland
      Endocrinology, Helsinki University Hospital and University of He
    Jul 8, 2022

    Esophageal Squamous Cell Carcinoma Trial in Xi'an (Tislelizumab + cisplatin + paclitaxel, Tislelizumab + radiotherapy)

    Enrolling by invitation
    • Esophageal Squamous Cell Carcinoma
    • Tislelizumab + cisplatin + paclitaxel
    • Tislelizumab + radiotherapy
    • Xi'an, Shaanxi, China
      The First Affiliated Hospital of Xi'an Jiaotong University
    Dec 21, 2022

    Advanced Solid Tumor, BRAF V600 Mutation Trial in Nanchang, Jinan, Shanghai (ABM-1310)

    Not yet recruiting
    • Advanced Solid Tumor
    • BRAF V600 Mutation
    • Nanchang, Jiangxi, China
    • +2 more
    Aug 12, 2022

    Laser Ablation After Stereotactic Radiosurgery

    Completed
    Has Results
    • Metastatic Brain Tumors
    • +3 more
      • New Haven, Connecticut
      • +6 more
      Aug 23, 2021

      Lung Tumor Malignant Trial in Jeollanam-do (Atezolizumab Injection [Tecentriq])

      Unknown status
      • Lung Neoplasm Malignant
      • Atezolizumab Injection [Tecentriq]
      • Jeollanam-do, 전라남도, Korea, Republic of
        Chonnam National University Hwasun Hospital
      Jan 26, 2021

      Prevalence of Osteoporosis in Sickle Cell Disease

      Recruiting
      • Sickle Cell Disease
      • Questionnaire
      • Lyon, France
        Hôpital Edouard Herriot
      Dec 8, 2021

      Hepatocellular Carcinoma Trial in Jinan (PD-1 plus stereotactic body radiotherapy)

      Recruiting
      • Hepatocellular Carcinoma
      • PD-1 plus stereotactic body radiotherapy
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      May 3, 2022

      Chronic Graft-versus-host-disease Trial in Goyang-si, Incheon, Seoul (SCM-CGH, Placebo)

      Recruiting
      • Chronic Graft-versus-host-disease
      • SCM-CGH
      • Placebo
      • Goyang-si, Gyeonggi-do, Korea, Republic of
      • +6 more
      Sep 26, 2021

      Fuchs Trial in United States (Topical Ripasudil, Topical Placebo)

      Recruiting
      • Fuchs
      • Topical Ripasudil
      • Topical Placebo
      • Palo Alto, California
      • +3 more
      Jan 18, 2023